<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100966035</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22040</journal-id>
<journal-id journal-id-type="nlm-ta">Trends Mol Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Trends Mol Med</journal-id>
<journal-title-group>
<journal-title>Trends in molecular medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-4914</issn>
<issn pub-type="epub">1471-499X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30578089</article-id>
<article-id pub-id-type="pmc">6377292</article-id>
<article-id pub-id-type="doi">10.1016/j.molmed.2018.11.004</article-id>
<article-id pub-id-type="manuscript">NIHMS1516993</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptional and epigenetic regulation of microglia in health and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yeh</surname>
<given-names>Hana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ikezu</surname>
<given-names>Tsuneya</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Graduate Program in Neuroscience, Boston University School of Medicine, Boston, MA 02118</aff>
<aff id="A2"><label>2</label>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA 02118</aff>
<aff id="A3"><label>3</label>Department of Neurology, Boston University School of Medicine, Boston, MA 02118</aff>
<author-notes>
<corresp id="CR1">Corresponding authors: Hana Yeh (<email>hyeh@bu.edu</email>) and Tsuneya Ikezu (<email>tikezu@bu.edu</email>), 72 East Concord St, L-606, Boston, MA 02118</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>25</volume>
<issue>2</issue>
<fpage>96</fpage>
<lpage>111</lpage>
<!--elocation-id from pubmed: 10.1016/j.molmed.2018.11.004-->
<abstract id="ABS1">
<p id="P1">Microglia are the resident immune cells that maintain brain homeostasis and contribute to neurodegenerative disorders. Recent studies of microglia at transcriptomic and epigenetic levels revealed specific molecular pathways that regulate microglia development, maturation and reactive states. The transcriptionfactor PU.1 plays a key role in regulating several microglial functions. Environmental factors such as microbiota, early life stress and maternal immune activation can dysregulate PU.1 and innate immune response. This review discusses the epigenetic regulation of key transcriptional factors in human and murine microglia, highlighting their networks for shaping the microglial function. PU.1 and other microglia-specific transcriptional factors can be further studied to determine their therapeutic applications in neurologic disorders.</p>
</abstract>
<kwd-group>
<kwd>Alzheimerâ€™s disease</kwd>
<kwd>autism spectrum disorders</kwd>
<kwd>early life stress</kwd>
<kwd>epigenetic</kwd>
<kwd>microglia</kwd>
<kwd>neurodegenerative disorders</kwd>
<kwd>PU.1</kwd>
<kwd>transcription factors</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>